Updates are available Correction dated 2023-09-02
Click to view Correction: https://doi.org/10.1007/s00005-023-00687-8
-
Authors
Śledź, Marta https://orcid.org/0000-0002-4497-3096
Wojciechowska, Alicja https://orcid.org/0009-0001-8720-8204
Zagożdżon, Radosław https://orcid.org/0000-0002-7957-2372
Kaleta, Beata https://orcid.org/0000-0002-0697-2594
-
Funding
Funding for this research was provided by:
Agencja Badań Medycznych (2020/ABM/04/00002-00)
- License Information
-
More Information
Article History
Received: 18 April 2023
Accepted: 5 June 2023
First Online: 7 July 2023
Change Date: 2 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00005-023-00687-8
Declarations
:
: Radoslaw Zagozdzon is an ad hoc scientific consultant for Pure Biologics S.A. (Wroclaw, Poland) and 4Cell Therapies S.A. (Gliwice, Poland). Other authors have no relevant financial or non-financial interests to disclose.
: Not applicable.
: All authors have read the manuscript and agreed to give their consent for the publication of information in the Archivum Immunologiae et Therapiae Experimentalis.
